How to search

Enter a search term in the search box at the top of the page, and press the "search" button.

The system searches the fields: First name, surname, research interests,current institute, city, country and nationality. The number of results are displayed directly under the search box, and the term queried is highlighted in the text.

Under the Search box at the top of the page, you will see the number of search results found for any one search.

You can filter a search by using the left-hand menu. Filters can only be applied AFTER you have begun a search. To cancel one or more filters, simply close the relevant filter from the "Filters" box at the top of the search list. The Filters box only appears after you have selected a filter from the left-hand menu.

Close (X)

Filters:
  • Draetta Group
 
About 4 results

  1. Veronique Baldin

    Current information Scientist Toulouse, France E-mail Nationality: French
    EMBL information Postdoctoral Fellow Draetta Group Developmental Biology From 1991 to 1992 Biography Hide biography
    Biography: Baldin V. et al., (1997) Oncogene, 14, 2485-2495.
    'Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implication for growth control'
    Baldin V. et al., (1997) Biochem. Biophys. Res. Commun.,236, 130-134.
    'Evidence for a mammalian Nim1-like kinase pathway controlling G1/S transition'
    Baldin V., et al., (1997) J. Biol. Chem., 272, 32731-32734.
    'Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation'
    Cans C., Ducommun B. and Baldin V. (1999)Molecular Biology Reports, 26, 53-57.
    'Proteasome-dependent degradation of human CDC25B phosphatase'
    Mils V., Baldin V., et al.,(2000) Oncogene, 19, 1257-1265.
    'Specific interaction between 14.3.3 isoforms and the human CDC25B phosphatase'
    Davezac N., Baldin V., et al., (2000) Oncogene, 19, 2179-2185.
    'Regulation of CDC25B phosphatase subcellular localisation'
    Baldin V. (2000) Progress in Cell Cycle Research, 4, 49-60 (Review).
    '14-3-3 proteins and growth control'
    *Davezac N., *Baldin V.,.(in press) Oncogene.
    'Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase. A potential role for pEg3 in cell cycle regulation.' (* equal contribution).
    Baldin V., Pelpel K., Cazalés M. Cans C. and Ducommun B. (in press) J. Biol. Chem.
    'Nuclear localisation of CDC25B1 and serine 146 integrity are required for induction of mitosis'

  2. Giulio Draetta

    Current information Professor, The University of Texas MD Anderson Cancer Center Institute for Applied Cancer Science
    1515 Holcombe Blvd. Unit 1954     Houston, USA E-mail Nationality: Italian
    EMBL information Group Leader Draetta Group Developmental Biology From 1990 to 1992

  3. Bernard Ducommun

    Current information Professor, University of Toulouse 118 route de Narbonne Toulouse, France E-mail Nationality: French
    EMBL information Postdoctoral Fellow Draetta Group Developmental Biology From 02.1990 to 12.1991 Research interests: Cell cycle

  4. Michele Pagano

    Current information Professor, New York University School of Medicine
    522 First Ave. SRB 1107     New York, USA E-mail Nationality: Italian
    EMBL information Postdoctoral Fellow Draetta Group Developmental Biology From 08.1990 to 11.1992 Research interests: CELL CYCLE, UBIQUITIN SYSTEM Biography Hide biography
    Biography: Dr. Pagano is an internationally recognized molecular and cell biologist who studies the cell division cycle and how the deregulation of this process contributes to malignant transformation. He received his doctorate in Medicine and a Specialty Diploma in Molecular Endocrinology in 1989 from the Federico II University in his native Napoli, Italy. He was subsequently a post-doctoral fellow at the EMBL, Heidelberg, Germany (1990-92) and a principal investigator and scientific co-founder of Mitotix Inc., Cambridge, MA (1992-96). He joined the NYU School of Medicine in September 1996 and has been the director of the Growth Control Program of the NYU Cancer Institute for the past eight years. He has received many prestigious grants and in 2006 obtained a MERIT Award from the National Cancer Institute in recognition of his outstanding achievements in cancer biology. In 2008, he was nominated Investigator at the Howard Hughes Medical Institute.